Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies

References

• Ali Z, Yousaf N, Larkin J. 2013. Melanoma epidemiology, biology and prognosis. EJC Suppl. 11:81–91.
   PubMedGoogle Scholar
• Belbasis L, Stefanaki I, Stratigos AJ, Evangelou E. 2016. Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: an umbrella review of meta-analyses. J Dermatol Sci. 84:330–339.
   PubMed Web of Science ®Google Scholar
• Bohn SK, Blomhoff R, Paur I. 2014. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 58:915–930.
   Web of Science ®Google Scholar
• Caini S, Cattaruzza S, Bendinelli B, Tosti G, Masala G, Gnagnarella P, Assedi M, Stanganelli I, Palli D, Gandini S. 2017. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. Eur J Nutr. 56:1–12.
   PubMed Web of Science ®Google Scholar
• Caini S, Masala G, Saieva C, Kvaskoff M, Savoye I, Sacerdote C, Hemmingsson O, Overvad K, Tjønneland A, Petersen KE, et al. 2017. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 140:2246–2255.
   PubMed Web of Science ®Google Scholar
• Conney AH, Lu YP, Lou YR, Kawasumi M, Nghiem P. 2013. Mechanisms of caffeine-induced inhibition of UVB carcinogenesis. Front Oncol. 3:144.
   PubMedGoogle Scholar
• Cronstein BN. 2011. Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep. 3:21.
   PubMedGoogle Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Fortes C, Mastroeni S, Boffetta P, Antonelli G, Pilla MA, Bottà G, Anzidei P, Venanzetti F. 2013. The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms. Cancer Cause Control. 24:1779–1787.
   PubMed Web of Science ®Google Scholar
• Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F, Grosso G. 2014. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr. 65:925–936.
   PubMed Web of Science ®Google Scholar
• Greenland S. 1987. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 9:1–30.
   PubMed Web of Science ®Google Scholar
• Greenland S, Longnecker MP. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 135:1301–1309.
   PubMed Web of Science ®Google Scholar
• Grosso G, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, Galvano F, Giovannucci E. 2017. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nut Rev. 75:405–419.
   PubMed Web of Science ®Google Scholar
• Grosso G, Godos J, Galvano F, Giovannucci EL. 2017. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 37:131–156.
   PubMed Web of Science ®Google Scholar
• Grosso G, Godos J, Lamuela-Raventos R, Ray S, Micek A, Pajak A, Sciacca S, D’Orazio N, Del Rio D, Galvano F. 2017. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol Nutr Food Res. 61:1600930.
   Web of Science ®Google Scholar
• Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Giovannucci EL. 2017. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epidemiol. 185:1304–1316.
   PubMed Web of Science ®Google Scholar
• Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, Giovannucci EL, Galvano F. 2016. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 31:1191–1205.
   PubMed Web of Science ®Google Scholar
• Hori A, Kasai H, Kawai K, Nanri A, Sato M, Ohta M, Mizoue T. 2014. Coffee intake is associated with lower levels of oxidative DNA damage and decreasing body iron storage in healthy women. Nutr Cancer. 66:964–969.
   PubMed Web of Science ®Google Scholar
• Karimi K, Lindgren TH, Koch CA, Brodell RT. 2016. Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer. Rev Endocr Metab Disord. 17:389–403.
   PubMed Web of Science ®Google Scholar
• Kim HG, Hwang YP, Han EH, Choi JH, Kwon KI, Chung YC, Jeong MH, Jeong MH, Jeong TC, Kang W. 2012. The coffee diterpene kahweol inhibits metastasis by modulating expressions of MMPs and VEGF via STAT3 inactivation. Food Chem. 133:1521–1529.
   Web of Science ®Google Scholar
• Lee WJ, Zhu BT. 2006. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis. 27:269–277.
   PubMed Web of Science ®Google Scholar
• Liang N, Kitts DD. 2014. Antioxidant property of coffee components: assessment of methods that define mechanisms of action. Molecules. 19:19180–19208.
   Web of Science ®Google Scholar
• Liu J, Shen B, Shi M, Cai J. 2016. Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: a meta-analysis study. PLoS One. 11:e0147056.
   PubMed Web of Science ®Google Scholar
• Lo JA, Fisher DE. 2014. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science. 346:945–949.
   PubMed Web of Science ®Google Scholar
• Loftfield E, Freedman ND, Graubard BI, Hollenbeck AR, Shebl FM, Mayne ST, Sinha R. 2015. Coffee drinking and cutaneous melanoma risk in the NIH-AARP diet and health study. J Natl Cancer Inst. doi: 10.1093/jnci/dju421"10.1093/jnci/dju421.
   PubMedGoogle Scholar
• Lukic M, Jareid M, Weiderpass E, Braaten T. 2016. Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study. BMC Cancer. 16:562.
   PubMed Web of Science ®Google Scholar
• Murzaku EC, Bronsnick T, Rao BK. 2014. Diet in dermatology: Part II. Melanoma, chronic urticaria, and psoriasis. J Am Acad Dermatol. 71:1053 e1051–1053 e1016.
   Web of Science ®Google Scholar
• Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. 2010. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Cause Control. 21:1533–1544.
   PubMed Web of Science ®Google Scholar
• Niseteo T, Komes D, Belščak-Cvitanović A, Horžić D, Budeč M. 2012. Bioactive composition and antioxidant potential of different commonly consumed coffee brews affected by their preparation technique and milk addition. Food Chem. 134:1870–1877.
   PubMed Web of Science ®Google Scholar
• Orsini NBR, Greenland S. 2006. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 6:40–57.
   Web of Science ®Google Scholar
• Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. 2012. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175:66–73.
   PubMed Web of Science ®Google Scholar
• Rota M, Pasquali E, Bellocco R, Bagnardi V, Scotti L, Islami F, Negri E, Boffetta P, Pelucchi C, Corrao G, et al. 2014. Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol. 170:1021–1028.
   PubMed Web of Science ®Google Scholar
• Salomone F, Galvano F, Li Volti G. 2017. Molecular bases underlying the hepatoprotective effects of coffee. Nutrients. 9:85.
   Web of Science ®Google Scholar
• Scurachio RS, Mattiucci F, Santos WG, Skibsted LH, Cardoso DR. 2016. Caffeine metabolites not caffeine protect against riboflavin photosensitized oxidative damage related to skin and eye health. J Photochem Photobiol B. 163:277–283.
   PubMed Web of Science ®Google Scholar
• Tong LX, Young LC. 2014. Nutrition: the future of melanoma prevention? J Am Acad Dermatol. 71:151–160.
   PubMed Web of Science ®Google Scholar
• Veierod MB, Thelle DS, Laake P. 1997. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer. 71:600–604.
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Zhang D. 2016. Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Eur J Nutr. 55:1317–1329.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P. 1999. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Proceedings of the Ottawa (Canada): Ottawa Health Research Institute.
   Google Scholar
• Wu H, Reeves KW, Qian J, Sturgeon SR. 2015. Coffee, tea, and melanoma risk among postmenopausal women. Eur J Cancer Prev. 24:347–352.
   PubMed Web of Science ®Google Scholar
• Wu S, Han J, Song F, Cho E, Gao X, Hunter DJ, Qureshi AA. 2015. Caffeine intake, coffee consumption, and risk of cutaneous malignant melanoma. Epidemiology. 26:898–908.
   PubMed Web of Science ®Google Scholar
• Yew YW, Lai YC, Schwartz RA. 2016. Coffee consumption and melanoma: a systematic review and meta-analysis of observational studies. Am J Clin Dermatol. 17:113–123.
   PubMed Web of Science ®Google Scholar